243 related articles for article (PubMed ID: 29884168)
1. Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany.
Dörr HG; Wollmann HA; Hauffa BP; Woelfle J;
BMC Endocr Disord; 2018 Jun; 18(1):37. PubMed ID: 29884168
[TBL] [Abstract][Full Text] [Related]
2. Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Falhammar H; Frisén L; Norrby C; Hirschberg AL; Almqvist C; Nordenskjöld A; Nordenström A
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2715-21. PubMed ID: 25279502
[TBL] [Abstract][Full Text] [Related]
3. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
4. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W; Schwarz HP
Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
[TBL] [Abstract][Full Text] [Related]
5. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
[TBL] [Abstract][Full Text] [Related]
7. Children with classic congenital adrenal hyperplasia experience salt loss and hypoglycemia: evaluation of adrenal crises during the first 6 years of life.
Odenwald B; Nennstiel-Ratzel U; Dörr HG; Schmidt H; Wildner M; Bonfig W
Eur J Endocrinol; 2016 Feb; 174(2):177-86. PubMed ID: 26563979
[TBL] [Abstract][Full Text] [Related]
8. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
9. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
[TBL] [Abstract][Full Text] [Related]
10. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in croatia between 1995 and 2006.
Dumic K; Krnic N; Skrabic V; Stipancic G; Cvijovic K; Kusec V; Stingl K
Horm Res; 2009; 72(5):310-4. PubMed ID: 19844117
[TBL] [Abstract][Full Text] [Related]
11. Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase-Deficiency: 13 Years of Neonatal Screening and Follow-up in Bavaria.
Odenwald B; Dörr HG; Bonfig W; Schmidt H; Fingerhut R; Wildner M; Nennstiel-Ratzel U
Klin Padiatr; 2015 Sep; 227(5):278-83. PubMed ID: 26090996
[TBL] [Abstract][Full Text] [Related]
12. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
Hargitai G; Sólyom J; Battelino T; Lebl J; Pribilincová Z; Hauspie R; Kovács J; Waldhauser F; Frisch H;
Horm Res; 2001; 55(4):161-71. PubMed ID: 11598369
[TBL] [Abstract][Full Text] [Related]
13. Presenting status of children with classical congenital adrenal hyperplasia over two decades (1999-2018) in the absence of newborn screening in Sri Lanka.
Seneviratne SN; Sandakelum U; Jayawardena CH; Weerasinghe AM; Wickramarachchi PS; de Silva S
J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1131-1137. PubMed ID: 34192833
[TBL] [Abstract][Full Text] [Related]
14. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia between 1995 and 2006.
Dumic K; Krnic N; Skrabic V; Stipancic G; Cvijovic K; Kusec V; Stingl K
Horm Res; 2009; 72(4):247-51. PubMed ID: 19786796
[TBL] [Abstract][Full Text] [Related]
15. How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia?
Grosse SD; Van Vliet G
Horm Res; 2007; 67(6):284-91. PubMed ID: 17199092
[TBL] [Abstract][Full Text] [Related]
16. Variations in the management of acute illness in children with congenital adrenal hyperplasia: An audit of three paediatric hospitals.
Chrisp GL; Maguire AM; Quartararo M; Falhammar H; King BR; Munns CF; Torpy DJ; Hameed S; Rushworth RL
Clin Endocrinol (Oxf); 2018 Nov; 89(5):577-585. PubMed ID: 30086199
[TBL] [Abstract][Full Text] [Related]
17. [Congenital adrenal hyperplasia: clinical aspects and neonatal screening].
Stikkelbroeck MM; Otten BJ
Ned Tijdschr Geneeskd; 2002 Feb; 146(6):246-9. PubMed ID: 11865652
[TBL] [Abstract][Full Text] [Related]
18. Congenital adrenal hyperplasia: lessons from a multinational study.
Frisch H; Waldhauser F; Lebl J; Solyom J; Hargitai G; Kovacs J; Pribilincova Z; Krzisnik C; Battelino T;
Horm Res; 2002; 57 Suppl 2():95-101. PubMed ID: 12065936
[TBL] [Abstract][Full Text] [Related]
19. Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: A total population study.
Engberg H; Butwicka A; Nordenström A; Hirschberg AL; Falhammar H; Lichtenstein P; Nordenskjöld A; Frisén L; Landén M
Psychoneuroendocrinology; 2015 Oct; 60():195-205. PubMed ID: 26184920
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of classical congenital adrenal hyperplasia.
Marumudi E; Khadgawat R; Surana V; Shabir I; Joseph A; Ammini AC
Steroids; 2013 Aug; 78(8):741-6. PubMed ID: 23624029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
